PT Kalbe Farma Tbk
Other OTCTotal Valuation
PT Kalbe Farma Tbk carries a market capitalization of 10.20M, placing it among publicly traded companies globally. Its enterprise value stands at 7,260.84T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 10.20M |
| Enterprise Value | 7,260.84T |
Share Statistics
PT Kalbe Farma Tbk currently has 45.25B shares outstanding.
| Shares Outstanding | 45.25B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
PT Kalbe Farma Tbk trades at a trailing price-to-earnings ratio of 12.30. The price-to-sales ratio is 1.26, and the price-to-book ratio stands at 298.55.
| PE Ratio | 12.30 |
| PS Ratio | 1.26 |
| PB Ratio | 298.55 |
| P/TBV Ratio | 329.77 |
| P/FCF Ratio | 52.92 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, PT Kalbe Farma Tbk trades at an EV/EBITDA multiple of 1,935.18 and an EV/FCF ratio of 10,375.01. The EV/Sales ratio of 251.98 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 1,935.18 provides insight into valuation relative to core operating earnings.
| EV / Sales | 251.98 |
| EV / EBITDA | 1,935.18 |
| EV / EBIT | 1,935.18 |
| EV / FCF | 10,375.01 |
Financial Position
PT Kalbe Farma Tbk maintains a current ratio of 3.15, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.20, indicating elevated leverage, while an interest coverage ratio of 218.65 demonstrates strong ability to service its debt obligations.
| Current Ratio | 3.15 |
| Quick Ratio | 0.75 |
| Debt / Equity | 3.20 |
| Debt / EBITDA | 0.22 |
| Interest Coverage | 218.65 |
Financial Efficiency
PT Kalbe Farma Tbk posts a return on equity of 12.64 and a return on invested capital of 11.33.
| Return on Equity (ROE) | 12.64 |
| Return on Assets (ROA) | 9.44 |
| Return on Invested Capital (ROIC) | 11.33 |
| Return on Capital Employed (ROCE) | 11.24 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.16 |
Taxes
Over the trailing twelve months, PT Kalbe Farma Tbk has paid 813.66B in income taxes, reflecting an effective tax rate of 21.21.
| Income Tax | 813.66B |
| Effective Tax Rate | 21.21 |
Stock Price Statistics
PT Kalbe Farma Tbk's stock has declined approximately -43.3606% over the past 52 weeks. The 50-day moving average sits at 8.71, while the 200-day moving average is 11.19.
| Beta (5Y) | N/A |
| 52-Week Price Change | -43.3606% |
| 50-Day Moving Average | 8.71 |
| 200-Day Moving Average | 11.19 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, PT Kalbe Farma Tbk generated 28.82T in revenue and converted that into 2.95T in net income, yielding earnings per share of 13,356.59. EBITDA reached 3.75T, while operating income came in at 3.75T.
| Revenue | 28.82T |
| Gross Profit | 14.35T |
| Operating Income | 3.75T |
| Pretax Income | 3.84T |
| Net Income | 2.95T |
| EBITDA | 3.75T |
| EBIT | 3.75T |
| Earnings Per Share (EPS) | 13,356.59 |
Balance Sheet
PT Kalbe Farma Tbk holds 4.99T in cash and equivalents against 825.35B in total debt, resulting in a net debt position of -4.05T. Total book value stands at 24.33T, with working capital of 14.33T providing operational flexibility.
| Cash & Cash Equivalents | 4.99T |
| Total Debt | 825.35B |
| Net Debt | -4.05T |
| Equity (Book Value) | 24.33T |
| Book Value Per Share | 537.67 |
| Working Capital | 14.33T |
Cash Flow
After subtracting -686.32B in capital expenditures, free cash flow totaled -686.32B - equivalent to -3,033.32 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -686.32B |
| Free Cash Flow | -686.32B |
| FCF Per Share | -3,033.32 |
Margins
PT Kalbe Farma Tbk operates with a gross margin of 18.87, reflecting its pricing power and cost economics. The operating margin of 13.02 and net profit margin of 10.25 provide insight into operational efficiency.
| Gross Margin | 18.87 |
| Operating Margin | 13.02 |
| Pretax Margin | 13.31 |
| Profit Margin | 10.25 |
| EBITDA Margin | 13.02 |
Dividends & Yields
The company's payout ratio of 0.00 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.00 |
| Dividend Yield | N/A |
| Payout Ratio | 0.00 |
| Shareholder Yield | 0.01 |
| FCF Yield | 1.89 |
Stock Splits
PT Kalbe Farma Tbk's most recent stock split took place on October 25, 2012 with a 1:5 split ratio.
| Last Split Date | 10/25/2012 |
| Split Ratio | 1:5 |
Scores
PT Kalbe Farma Tbk posts an Altman Z-Score of 598.94, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 598.94 |